Genomic determinants of motor and cognitive outcomes in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 7, 2012, Pages 881-886

  Chung, Sun Ju ^a,b   Armasu, Sebastian M ^a   Biernacka, Joanna M ^a   Anderson, Kari J ^a   Lesnick, Timothy G ^a   Rider, David N ^a   Cunningham, Julie M ^a   Eric Ahlskog, J ^a   Frigerio, Roberta ^c   Maraganore, Demetrius M ^c  

^a MAYO CLINIC   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Genome wide association studies; Outcomes; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; C8ORF4 GENE; CLINICAL ASSESSMENT; CLRN3 GENE; COGNITION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR CORTEX; MOTOR PERFORMANCE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; COGNITION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOTOR ACTIVITY; NEOPLASM PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865312376     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.04.025     Document Type: Article

References (28)

1. Elbaz A., Bower J.H., Peterson B.J., Maraganore D.M., McDonnell S.K., Ahlskog J.E., et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 2003, 60:91-96.
2. Alves G., Wentzel-Larsen T., Aarsland D., Larsen J.P. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 2005, 65:1436-1441.
3. Buter T.C., van den Hout A., Matthews F.E., Larsen J.P., Brayne C., Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 2008, 70:1017-1022.
4. Hely M.A., Morris J.G., Reid W.G., Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005, 20:190-199.
5. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008, 23:837-844.
6. Rajput A.H., Voll A., Rajput M.L., Robinson C.A., Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 2009, 73:206-212.
7. Goris A., Williams-Gray C.H., Clark G.R., Foltynie T., Lewis S.J., Brown J., et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 2007, 62:145-153.
8. Jasinska-Myga B., Opala G., Goetz C.G., Tustanowski J., Ochudlo S., Gorzkowska A., et al. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Arch Neurol 2007, 64:261-265.
9. Pankratz N., Wilk J.B., Latourelle J.C., DeStefano A.L., Halter C., Pugh E.W., et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 2009, 124:593-605.
10. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005, 77:685-693.
11. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999, 52:1214-1220.
12. Hinds D.A., Stuve L.L., Nilsen G.B., Halperin E., Eskin E., Ballinger D.G., et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005, 307:1072-1079.
13. Plassman B.L., Newman T.T., Welsh K.A., Helms M., Breitner J.C.S. Properties of the telephone interview for cognitive status: application in epidemiological and longitudinal studies. Neuropsychiatry Neuropsychol Behav Neurol 1994, 7:235-241.
14. Galvin J.E., Roe C.M., Powlishta K.K., Coats M.A., Muich S.J., Grant E., et al. The AD8: a brief informant interview to detect dementia. Neurology 2005, 65:559-564.
15. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
16. Jung Y., Bang S., Choi K., Kim E., Kim Y., Kim J., et al. TC1 (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby. Cancer Res 2006, 66:723-728.
17. Kim Y., Kim J., Park J., Bang S., Jung Y., Choe J., et al. TC1(C8orf4) is upregulated by IL-1beta/TNF-alpha and enhances proliferation of human follicular dendritic cells. FEBS Lett 2006, 580:3519-3524.
18. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol 2009, 8:382-397.
19. Dobbs R.J., Charlett A., Purkiss A.G., Dobbs S.M., Weller C., Peterson D.W. Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand 1999, 100:34-41.
20. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 1995, 202:17-20.
21. Chen H., Jacobs E., Schwarzschild M.A., McCullough M.L., Calle E.E., Thun M.J., et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 2005, 58:963-967.
22. Ritz B., Rhodes S.L., Qian L., Schernhammer E., Olsen J.H., Friis S. L-type calcium channel blockers and Parkinson disease in Denmark. Ann Neurol 2010, 67:600-606.
23. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007, 8:519-529.
24. Mikoshiba K. Inositol 1,4,5-trisphosphate IP(3) receptors and their role in neuronal cell function. J Neurochem 2006, 97:1627-1633.
25. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69:1074-1083.
26. Wang W.Y., Barratt B.J., Clayton D.G., Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005, 6:109-118.
27. Rocca W.A., Peterson B.J., McDonnell S.K., Bower J.H., Ahlskog J.E., Schaid D.J., et al. The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005, 24:151-167.
28. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Kruger R., et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006, 296:661-670.